SULFASALAZINE

Sulfasalazine was initially approved by the United States Food and Drug Administration (FDA) on December 30, 1950.

Sulfasalazine is used in a range of inflammatory conditions. It is commonly used as a disease-modifying antirheumatic drug (DMARD) to manage rheumatoid arthritis, lessening joint inflammation and pain. Moreover, the medication proves valuable in treating inflammatory bowel diseases like ulcerative colitis and Crohn's disease, aiding in the reduction of intestinal inflammation and the alleviation of associated symptoms.

Sulfasalazine is typically administered orally in the form of tablets. It is important to follow your healthcare provider's instructions on how to take the medication.

Common effects encompass gastrointestinal discomfort, nausea, vomiting, headache, loss of appetite, and rash. Serious reactions involve hypersensitivity reactions, liver issues, blood disorders, lung complications, and infrequent but severe skin reactions such as Stevens-Johnson syndrome.

Sulfasalazine can trigger hypersensitivity reactions, including severe allergic responses. It can affect liver function, leading to liver problems. This medication may impact blood cell production, potentially leading to disorders such as agranulocytosis (low white blood cell count), anemia, or thrombocytopenia (low platelet count). Serious skin reactions, such as Stevens-Johnson syndrome, can occur.It can also increase sensitivity to sunlight.

Individuals with a history of allergies to sulfa drugs or hypersensitivity should exercise caution before starting Sulfasalazine. Regular monitoring of liver enzymes is advised, especially during the initial months of treatment. Regular blood tests are important to monitor for blood disorders. If you notice unusual bleeding, easy bruising, or signs of infection, report them to your healthcare provider. If rash or skin reactions develop, immediate medical attention is required. Sunscreen and protective clothing are recommended to avoid sunburn.

Allergic reactions, liver problems, blood disorders, and lung issues are serious concerns that require immediate medical attention if experienced. Monitoring liver and kidney function is important, and individuals with kidney issues should use Sulfasalazine cautiously. Gastrointestinal discomfort, sensitivity to sunlight, and potential interactions with alcohol and certain medications are common considerations. For those with diabetes, infections, or surgeries planned, consulting a healthcare provider is essential. Fertility concerns, eye examinations, and the risk of methemoglobinemia should also be discussed. Comprehensive monitoring, especially blood counts and organ function, is vital. Always follow your healthcare provider's guidance and openly communicate about your health history and concerns to ensure safe and effective use of medication.

Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout, 12th edition, 2011, 993. KD Tripathi, Essentials of Medical Pharmacology, Antirheumatoid and antigout drugs, 7th edition, 2013, 212. Pfizer, Electronic medicines compendium (emc), [Revised on 10th Aug 2023] [ Accessed on 25th August 2023], https://www.medicines.org.uk/emc/product/3838/smpc#gref Pfizer, US Food and Drug Administration, [Revised on 2009] [ Accessed on 25th August], https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/007073s124lbl.pdf